New Blood Test May Help Detect 50 (Plus!) Cancers

Why is this so cool? Because early detection is key to effective cancer treatment and better outcomes overall.

by Lara DeSanto Health Writer

Cancer screening requires a battery of tests and procedures, depending on the specific cancer—some more complicated than others. And for some cancers—like cancers of the head and neck—there aren’t effective screening tests available that can detect the cancer early. But there’s a new breakthrough in cancer testing that may change that and seriously improve the cancer screening process as a whole.

New technology allows one simple blood test to look for more than 50 different types of cancers—and pinpoint their location in the body, according to a study published in Annals of Oncology. The new test, designed by GRAIL, Inc., was even able to catch several dangerous cancers that don’t have established screening approaches.

The study, performed by researchers at Dana-Farber Cancer Institute and the Mayo Clinic on thousands of participants, suggests that this new test could play a major role in the early detection of these 50-plus cancers—which is particularly exciting because early detection is often the key to good treatment.

Types of cancers the test may be able to detect include breast, colorectal, esophageal, bladder, gallbladder, gastric, ovarian, lung, head and neck, multiple myeloma, lymphoid leukemia, and pancreatic cancer.

To find these cancers, the test analyzes what are called methyl groups on the DNA of cancer cells. Basically, you get your blood drawn, and DNA from the blood sample is examined in a lab to look for signs of a bunch of different cancers in one go.

Researchers looked at 6,689 blood samples in the study—2,482 from people already diagnosed with cancer (with more than 50 cancer types represented) and 4,207 from people without cancer. For a group of 12 cancers that account for about two-thirds of cancer deaths in the United States, the test was able to detect them two-thirds of the time—pretty darn accurate by screening test standards. Of those, the test correctly identified stage I cancer—meaning the cancer is in an early stage—nearly 40% of the time.

"Our results show that this approach to testing cell-free DNA in blood can detect a broad range of cancer types at virtually any stage of the disease, with specificity and sensitivity approaching the level needed for population-level screening," study author Geoffrey Oxnard, M.D., a medical oncologist at Dana-Farber, said in a news release. "The test can be an important part of clinical trials for early cancer detection."

Only people who are part of the current clinical study at Dana-Farber can access the blood test right now—but it’s possible it would become more widely available in the coming years.

The Importance of Early Detection

Catching cancer early can seriously improve the outcomes of treatment, according to the National Cancer Institute (NCI). And that’s where screening tests—like this new blood test—come in. They’re used to help find these cancers before they even cause noticeable symptoms. If you can catch a cancer at this early stage, it’s likely going to be easier to treat.

Some of the other most effective screening tests for early detection—or complete prevention of cancers—include the following, per the NCI:

  • Colonoscopy. This is a test—along with sigmoidoscopy and stool tests—that helps detect colorectal cancer, according to the NCI. These tests can actually detect abnormal growths in the colon before they’re even considered cancer at all. Most healthy adults ages 45-75 should get regular colon cancer screening.

  • Mammography. Mammograms are X-rays done on the breasts to screen for breast cancer in women. Typically, women between 40 and 74 should get regular mammograms.

  • Human papillomavirus testing. Testing for human papillomavirus (HPV), which includes Pap tests, help your doctor detect any abnormal cells in your cervix before they become cancer. Usually women between 21 and 65 should receive this regular screening for cervical cancer.

  • Low-dose helical computed tomography. This is a test used to screen for lung cancer that uses low-dose radiation to take picture of the inside of your body. It’s been shown to reduce the risk of dying from lung cancer in people who are heavy smokers.

There are other cancer screening tests out there too—but these are some of the most effective. Talk to your health care provider about your personal risk factors for cancer and what screenings you should be receiving regularly.

Lara DeSanto
Meet Our Writer
Lara DeSanto

Lara is a former digital editor for HealthCentral, covering Sexual Health, Digestive Health, Head and Neck Cancer, and Gynecologic Cancers. She continues to contribute to HealthCentral while she works towards her masters in marriage and family therapy and art therapy. In a past life, she worked as the patient education editor at the American College of OB-GYNs and as a news writer/editor at